Ms Siew Ping Goh

Siew-Ping is a pharmacist by training and started her career in Quintiles in 1998, specializing in clinical trial drug safety. She is currently the Director of Pharmacovigilance based in the Asia-Pacific regional Quintiles office in Singapore and leads a continuously growing team of currently 20 pharmacovigilance specialists and coordinators. Siew-Ping’s team in Singapore provides full scope pharmacovigilance services to pharma and biotech companies, covering 14 countries in the Asia-Pacific region including South East Asia, Australia/NZ, Greater China, Japan, Korea and India.

Being in the drug safety industry for more than 10 years, Siew-Ping has an in-depth knowledge of the pharmacovigilance practices both globally and regionally, and is very well versed in the safety reporting requirements of the regulatory agencies in the Asia-Pacific region. She has numerous experiences working as the Asia-Pacific Pharmacovigilance Lead in large Phase 2 to 4 multinational studies of various indications, and has also performed the Global Pharmacovigilance Lead role for a number of studies. She has also been involved in setting up and management of study oversight groups such as clinical events committee (CEC) and Data Safety Monitoring Board (DSMB).

Siew-Ping has a lot of experience training investigators and CRAs on SAE reporting and pharmacovigilance practices. She is also a speaker on clinical trial drug safety for a number of clinical trial conferences in the region.